Immunogenicity and clinical protection against equine influenza by DNA vaccination of ponies

Vaccine

Volumn 30, Issue 26, 2012, Pages 3965-3974

  Ault, Alida ^a   Zajac, Alyse M ^a   Kong, Wing Pui ^a   Gorres, J Patrick ^a   Royals, Michael ^c   Wei, Chih Jen ^a   Bao, Saran ^a   Yang, Zhi yong ^a   Reedy, Stephanie E ^b   Sturgill, Tracy L ^b   Page, Allen E ^b   Donofrio Newman, Jennifer ^b   Adams, Amanda A ^b   Balasuriya, Udeni B R ^b   Horohov, David W ^b   Chambers, Thomas M ^b   Nabel, Gary J ^a   Rao, Srinivas S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c PharmaJet Inc   (United States)

Author keywords

DNA vaccine; Equine; Immunogenicity; Influenza; Protection

Indexed keywords

DNA VACCINE; EQUINE INFLUENZA VACCINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; EQUINE INFLUENZA; FEVER; HEMAGGLUTINATION INHIBITION; HORSE; IMMUNIZATION; IMMUNOGENICITY; INJECTION SITE SWELLING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HORSE DISEASES; HORSES; INFLUENZA A VIRUS, H3N8 SUBTYPE; INFLUENZA VACCINES; MICE; ORTHOMYXOVIRIDAE INFECTIONS; VACCINATION; VACCINES, DNA;

EID: 84861199412     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.03.026     Document Type: Article

References (63)

1. Aerts J., Gonzalez M., Topalian S. Selection of appropriate control genes to assess expression of tumor antigens using real-time RT-PCR. Biotechniques 2004, 36:84-86. 88, 90.
2. Amorij J.P., Hinrichs W.L., Frijlink H.W., Wilschut J.C., Huckriede A. Needle-free influenza vaccination. Lancet Infect Dis 2010, 10:699-711.
3. Barouch D.H., Yang Z.y., Kong W.p., Korioth-Schmitz B., Sumida S.M., Truitt D.M., et al. A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates. J Virol 2005, 79:8828-8834.
4. Boliar S., Stanislawek W., Chambers T.M. Inability of kaolin treatment to remove nonspecific inhibitors from equine serum for the hemagglutination inhibition test against equine H7N7 influenza virus. J Vet Diagn Invest 2006, 18:264-267.
5. Breathnach C.C., Clark H.J., Clark R.C., Olsen C.W., Townsend H.G., Lunn D.P. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge. Vaccine 2006, 24:1180-1190.
6. Bryant N.A., Rash A.S., Russell C.A., Ross J., Cooke A., Bowman S., et al. Antigenic and genetic variations in European and North American equine influenza virus strains (H3N8) isolated from 2006 to 2007. Vet Microbiol 2009, 138:41-52.
7. Bryant N.A., Rash A.S., Woodward A.L., Medcalf E., Helwegen M., Wohlfender F., et al. Isolation and characterisation of equine influenza viruses (H3N8) from Europe and North America from 2008 to 2009. Vet Microbiol 2011, 147:19-27.
8. Chambers T.M., Holland R.E., Tudor L.R., Townsend H.G., Cook A., Bogdan J., et al. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet J 2001, 33:630-636.
9. Chambers T.M., Quinlivan M., Sturgill T., Cullinane A., Horohov D.W., Zamarin D., et al. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet J 2009, 41:87-92.
10. Crouch C.F., Daly J., Henley W., Hannant D., Wilkins J., Francis M.J. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses. Vet Immunol Immunopathol 2005, 108:345-355.
11. Cullinane A., Elton D., Mumford J. Equine influenza-surveillance and control. Influenza Other Respi Viruses 2010, 4:339-344.
12. Daly J.M., MacRae S., Newton J.R., Wattrang E., Elton D.M. Equine influenza: a review of an unpredictable virus. Vet J 2011, 189:7-14.
13. Daly J.M., Newton J.R., Mumford J.A. Current perspectives on control of equine influenza. Vet Res 2004, 35:411-423.
14. Daly J.M., Sindle T., Tearle J., Barquero N., Newton J.R., Corning S. Equine influenza vaccine containing older H3N8 strains offers protection against A/eq/South Africa/4/03 (H3N8) strain in a short-term vaccine efficacy study. Equine Vet J 2007, 39:446-450.
15. Dheda K., Huggett J.F., Bustin S.A., Johnson M.A., Rook G., Zumla A. Validation of housekeeping genes for normalizing RNA expression in real-time PCR. Biotechniques 2004, 37:112-114. 116, 118.
16. Drunen Littel-van den Hurk S., Babiuk S., Babiuk L.A. Needle-free delivery of veterinary DNA vaccines. Ann N Y Acad Sci 2006, 91-105.
17. Edlund T.C., Daly J., Sindle T., Guigal P.M., Audonnet J.C., Minke J.M. Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom. Vet Rec 2005, 156:367-371.
18. Ekwueme D.U., Weniger B.G., Chen R.T. Model-based estimates of risks of disease transmission and economic costs of seven injection devices in sub-Saharan Africa. Bull World Health Organ 2002, 80:859-870.
19. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997, 158:2278-2284.
20. Gorres J.P., Lager K.M., Kong W.P., Royals M., Todd J.P., Vincent A.L., et al. DNA vaccination elicits protective immune responses against pandemic and classic swine influenza viruses in pigs. Clin Vaccine Immunol 2011, 18:1987-1995.
21. Heldens J.G., Pouwels H.G., Derks C.G., Van de Zande S.M., Hoeijmakers M.J. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap. Vaccine 2009, 27:5530-5537.
22. Heldens J.G.M., Pouwels H.G.W., Derks C.G.G., Van de Zande S.M.A., Hoeijmakers M.J.H. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix. Vaccine 2010, 28:6989-6996.
23. Huber V.C., McKeon R.M., Brackin M.N., Miller L.A., Keating R., Brown S.A., et al. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza. Clin Vaccine Immunol 2006, 13:981-990.
24. Huber V.C., Thomas P.G., McCullers J.A. A multi-valent vaccine approach that elicits broad immunity within an influenza subtype. Vaccine 2009, 27:1192-1200.
25. Johnson P.A., Conway M., Daly J., Nicolson C., Robertson J.S., Mills K.H.G. Influenza HA DNA induces Th1 cells and protection despite limited antibody responses. Int Congr Ser 2001, 1219:911-915.
26. Kannegieter N.J., Frogley A., Crispe E., Kirkland P.D. Clinical outcomes and virology of equine influenza in a naive population and in horses infected soon after receiving one dose of vaccine. Aust Vet J 2011, 89(Suppl. 1):139L 142.
27. Kong W.-P., Hood C., Yang Z.-Y., Wei C.-J., Xu L., Garcia-Sastre A., et al. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc Natl Acad Sci USA 2006, 103:15987-15991.
28. Kutzler M.A., Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 2008, 9:776-788.
29. Letvin N.L., Rao S.S., Montefiori D.C., Seaman M.S., Sun Y., Lim S.Y., et al. Immune and genetic correlates of vaccine protection against mucosal infection by SIV in monkeys. Sci Transl Med 2011, 3:81ra36.
30. Lewis N.S., Daly J.M., Russell C.A., Horton D.L., Skepner E., Bryant N.A., et al. Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007. J Virol 2011, 85:12742-12749.
31. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[delta][delta]CT method. Methods 2001, 25:402-408.
32. Lopez A.M., Hecker R., Mutwiri G., van Drunen Littel-van den Hurk, Babiuk L.A., Townsend H.G.G. Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet Immunol Immunopathol 2006, 114:103-110.
33. Lu Z., Chambers T.M., Boliar S., Branscum A.J., Sturgill T.L., Timoney P.J., et al. Development and evaluation of one-step TaqMan real-time reverse transcription-PCR Assays targeting nucleoprotein, matrix, and hemagglutinin genes of equine influenza virus. J Clin Microbiol 2009, 47:3907-3913.
34. Lunn D.P., Hussey S., Sebing R., Rushlow K.E., Radecki S.V., Whitaker-Dowling P., et al. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. J Am Vet Med Assoc 2001, 218:900-906.
35. Lunn D.P., Soboll G., Schram B.R., Quass J., McGregor M.W., Drape R.J., et al. Antibody responses to DNA vaccination of horses using the influenza virus hemagglutinin gene. Vaccine 1999, 17:2245-2258.
36. Minke J.M., Toulemonde C.E., Coupier H., Guigal P.M., Dinic S., Sindle T., et al. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge. Am J Vet Res 2007, 68:213-219.
37. Morley P.S., Townsend H.G., Bogdan J.R., Haines D.M. Efficacy of a commercial vaccine for preventing disease caused by influenza virus infection in horses. J Am Vet Med Assoc 1999, 215:61-66.
38. Mumford J., Wood J.M., Scott A.M., Folkers C., Schild G.C. Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J Hyg (Lond) 1983, 90:385-395.
39. Mumford J.A., Hannant D., Jessett D.M. Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. Equine Vet J 1990, 22:93-98.
40. Mumford J.A., Wood J.M., Folkers C., Schild G.C. Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus. Epidemiol Infect 1988, 100:501-510.
41. Nelson K.M., Schram B.R., McGregor M.W., Sheoran A.S., Olsen C.W., Lunn D.P. Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination. Vaccine 1998, 16:1306-1313.
42. Newton J.R., Townsend H.G., Wood J.L., Sinclair R., Hannant D., Mumford J.A. Immunity to equine influenza: relationship of vaccine-induced antibody in young Thoroughbred racehorses to protection against field infection with influenza A/equine-2 viruses (H3N8). Equine Vet J 2000, 32:65-74.
43. OIE Equine influenza. OIE manual of diagnostic tests and vaccines for terrestrial animals 2004, Office International des Epizooties, Paris, p. 686-97.
44. Paillot R., Hannant D., Kydd J.H., Daly J.M. Vaccination against equine influenza: quid novi?. Vaccine 2006, 24:4047-4061.
45. Paillot R., Kydd J.H., Sindle T., Hannant D., Edlund Toulemonde C., Audonnet J.C., et al. Antibody and IFN-[gamma] responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus. Vet Immunol Immunopathol 2006, 112:225-233.
46. Quinlivan M., Nelly M., Prendergast M., Breathnach C., Horohov D., Arkins S., et al. Pro-inflammatory and antiviral cytokine expression in vaccinated and unvaccinated horses exposed to equine influenza virus. Vaccine 2007, 25:7056-7064.
47. Rainen L., Oelmueller U., Jurgensen S., Wyrich R., Ballas C., Schram J., et al. Stabilization of mRNA expression in whole blood samples. Clin Chem 2002, 48:1883-1890.
48. Rao S.S., Kong W.P., Wei C.J., Yang Z.Y., Nason M., Styles D., et al. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice. PLoS ONE 2008, 3.
49. Rao S.S., Styles D., Kong W., Andrews C., Gorres J.P., Nabel G.J. A gene-based avian influenza vaccine in poultry. Poult Sci 2009, 88:860-866.
50. Reed L.J., Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 1938, 27:493-497.
51. Shipley J.M., Miller R.D., Wu B.M., Grubb J.H., Christensen S.G., Kyle J.W., et al. Analysis of the 5' flanking region of the human beta-glucuronidase gene. Genomics 1991, 10:1009-1018.
52. Shu Y., Winfrey S., Yang Z.Y., Xu L., Rao S., Srivastava I., et al. Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. Vaccine 2007, 25:1398-1408.
53. Soboll G., Horohov D.W., Aldridge B.M., Olsen C.W., McGregor M.W., Drape R.J., et al. Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination. Vet Immunol Immunopathol 2003, 94:47-62.
54. Soboll G., Hussey S.B., Minke J.M., Landolt G.A., Hunter J.S., Jagannatha S., et al. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination. Vet Immunol Immunopathol 2010, 135:100-107.
55. Soboll G., Nelson K.M., Leuthner E.S., Clark R.J., Drape R., Macklin M.D., et al. Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response. Vaccine 2003, 21:3081-3092.
56. Song K., Bolton D.L., Wei C.J., Wilson R.L., Camp J.V., Bao S., et al. Genetic immunization in the lung induces potent local and systemic immune responses. Proc Natl Acad Sci USA 2010, 107:22213-22218.
57. Townsend H.G., Penner S.J., Watts T.C., Cook A., Bogdan J., Haines D.M., et al. Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials. Equine Vet J 2001, 33:637-643.
58. United States Department of Agriculture. USDA issues license for West Nile Virus DNA vaccine for horses. 2005 [online]. http://www.aphis.usda.gov/lpa/news/2005/07/wnvdna_vs.%20html.
59. van M.C., Cullinane A. Equine influenza virus infections: an update. Vet Q 2002, 24:79-94.
60. Wattrang E., Jessett D.M., Yates P., Fuxler L., Hannant D. Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses. Viral Immunol 2003, 16:57-67.
61. Wei C.J., Boyington J.C., McTamney P.M., Kong W.P., Pearce M.B., Xu L., et al. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010, 329:1060-1064.
62. Wood J.M., Mumford J., Folkers C., Scott A.M., Schild G.C. Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. J Hyg (Lond) 1983, 90:371-384.
63. Wright P.F. Vaccine preparedness-are we ready for the next influenza pandemic?. N Engl J Med 2008, 358:2540-2543.